NuvOx Therapeutics
PrivateLast Round
Grant
Sep 26, 2025
Total Funding Raised
$20.69M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NuvOx Therapeutics is a clinical-stage biopharmaceutical company developing a first-in-class oxygen therapeutic designed to reverse tissue hypoxia in life-threatening diseases such as cancer, stroke, and respiratory distress.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuvOx Therapeutics Comparables
Compare NuvOx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prolong Pharmaceuticals, LLC | 88% | |
| Omniox, Inc. | 83% | |
| Aurum Biosciences Ltd | 81% | |
NuvOx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 26, 2025 | ||||
| Convertible Debt | Sep 18, 2023 | ||||
| Grant | Feb 11, 2022 | ||||
| Grant | Apr 12, 2017 | ||||
| Grant | Oct 17, 2014 |
Key People
Founding team and executive leadership
NuvOx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Gulf South Angels | Convertible Debt |
| VisionTech Partners | Convertible Debt |
| U.S. Department of War | Grant |
| MEDA Angels | Convertible Debt |
| National Heart, Lung, and Blood Institute | Grant |
| New World Angels | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 26, 2025
$2M grant from the National Cancer Institute
- Jul 23, 2025
Grew 30% QoQ, from 10 to 13 employees.
NuvOx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NuvOx Therapeutics's valuation, stock price, and market status.